Market revenue in 2023 | USD 57.7 million |
Market revenue in 2030 | USD 111.2 million |
Growth rate | 9.8% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 56.85% in 2023. Horizon Databook has segmented the Germany deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in funding for research projects to investigate other clinical applications of deep brain stimulation devices, such as deep brain stimulation project CHL-LCSB-TUAS funded by Luxembourg National Research Fund (FNR) and another project funded by Stiftung Rheinland-Pfalz, is anticipated to present lucrative growth opportunities for deep brain stimulation devices in this country.
For instance, University of Texas Health Science Center at Houston collaborated with University Hospital Bonn in Germany to conduct efficacy studies of deep brain stimulation devices in treatment-resistant depression.
Thus, increasing awareness and demand for minimally invasive surgical techniques, such as deep brain stimulation devices therapy, for the treatment of neurodegenerative diseases such as PD and rising funding for research activities are among the factors expected to drive the market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account